# Institute for Neurodegenerative Disorders

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/institute-for-neurodegenerative-disorders/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 81 |
| Citations | 736,491 |
| City | New Haven |
| Country | US |
| Description | Institute for Neurodegenerative Disorders is a research organisation in New Haven, US. OpenAlex records 4,472 works and 736,491 citations for it. 1,203 researchers list it as their most recent affiliation. |
| Homepage | http://www.indd.org/ |
| OpenAlex ID | https://openalex.org/I4210111938 |
| Researchers | 1,203 |
| ROR ID | https://ror.org/022hrs427 |
| Type | nonprofit |
| Works | 4,472 |

## University papers

Showing 12 of 13.

- [MDS clinical diagnostic criteria for Parkinson's disease](https://scholariq.org/papers/mds-clinical-diagnostic-criteria-for-parkinson-s-disease/)
- [The Parkinson Progression Marker Initiative (PPMI)](https://scholariq.org/papers/the-parkinson-progression-marker-initiative-ppmi/)
- [MDS research criteria for prodromal Parkinson's disease](https://scholariq.org/papers/mds-research-criteria-for-prodromal-parkinson-s-disease/)
- [Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study](https://scholariq.org/papers/assessment-of-heterogeneity-among-participants-in-the-parkinson-s-progression/)
- [The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort](https://scholariq.org/papers/the-parkinson-s-progression-markers-initiative-ppmi-establishing-a-pd-biomarker/)
- [A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research](https://scholariq.org/papers/a-biological-definition-of-neuronal-synuclein-disease-towards-an-integrated/)
- [The role of radiotracer imaging in Parkinson disease](https://scholariq.org/papers/the-role-of-radiotracer-imaging-in-parkinson-disease/)
- [Targeting Prodromal Alzheimer Disease With Avagacestat](https://scholariq.org/papers/targeting-prodromal-alzheimer-disease-with-avagacestat/)
- [Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort](https://scholariq.org/papers/longitudinal-change-of-clinical-and-biological-measures-in-early-parkinson-s/)
- [Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression](https://scholariq.org/papers/validation-of-serum-neurofilament-light-chain-as-a-biomarker-of-parkinson-s/)
- [Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression](https://scholariq.org/papers/effect-of-urate-elevating-inosine-on-early-parkinson-disease-progression/)
- [Finding useful biomarkers for Parkinson’s disease](https://scholariq.org/papers/finding-useful-biomarkers-for-parkinson-s-disease/)

## University top topics

Showing 8 of 25.

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Neurological disorders and treatments](https://scholariq.org/topics/neurological-disorders-and-treatments/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)
- [Prion Diseases and Protein Misfolding](https://scholariq.org/topics/prion-diseases-and-protein-misfolding/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.